×
About 8,148 results

ALLMedicine™ Intracranial Hemorrhage Center

Research & Reviews  2,701 results

Endovascular Therapy versus No Endovascular Therapy in Patients receiving Best Medical ...
https://doi.org/10.1111/ene.15410
European Journal of Neurology; Berberich A, Finitsis S et. al.

May 20th, 2022 - Endovascular therapy (EVT) is increasingly reported for treatment of isolated posterior cerebral artery (PCA) occlusions although its clinical benefit remains uncertain. This study-level meta-analysis investigated functional outcome and safety of ...

Comparative hemostatic efficacy of 4F-PCC in patients with intracranial hemorrhage on f...
https://doi.org/10.1016/j.ajem.2022.04.044
The American Journal of Emergency Medicine; Heath M, Hall B et. al.

May 18th, 2022 - Patients experiencing an intracranial hemorrhage (ICH) on oral anticoagulants often require rapid reversal. This study evaluated patients taking factor Xa inhibitors or warfarin that received reversal with 4-factor prothrombin complex concentrate ...

Surgical Timing in Patients With Infective Endocarditis and With Intracranial Hemorrhag...
https://doi.org/10.1161/JAHA.121.024401
Journal of the American Heart Association; Musleh R, Schlattmann P et. al.

May 17th, 2022 - Background Intracranial hemorrhage (ICH) is one of the main causes for lack of surgery in patients with infective endocarditis (IE), despite the presence of surgical indications. We aimed to evaluate the impact of early surgery in patients with IE...

Prevalence of intracranial hemorrhage amongst patients presenting with out-of-hospital ...
https://doi.org/10.1016/j.resuscitation.2022.05.001
Resuscitation Yi Lee K, Zheng So W et. al.

May 14th, 2022 - An unknown proportion of out-of-hospital cardiac arrest (OHCA) is caused by intracranial hemorrhage (ICH). There is uncertainty over the role of early head computed tomography (CT) in non-traumatic OHCA due to uncertain diagnostic yield and ways t...

see more →

Guidelines  4 results

Recommended Primary Outcomes for Clinical Trials Evaluating Hemostatic Agents in Patien...
https://doi.org/10.1001/jamanetworkopen.2021.23629
JAMA Network Open; Mayer SA, Frontera JA et. al.

Sep 3rd, 2021 - In patients with acute spontaneous or traumatic intracranial hemorrhage, early hemostasis is thought to be critical to minimize ongoing bleeding. However, research evaluating hemostatic therapies has been hampered by a lack of standardized clinica...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
https://doi.org/10.1016/j.jacr.2020.01.036
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Platelet transfusion: a clinical practice guideline from the AABB.
https://doi.org/10.7326/M14-1589
Annals of Internal Medicine; Kaufman RM, Djulbegovic B et. al.

Nov 11th, 2014 - The AABB (formerly, the American Association of Blood Banks) developed this guideline on appropriate use of platelet transfusion in adult patients. These guidelines are based on a systematic review of randomized, clinical trials and observational ...

Hemorrhage from cavernous malformations of the brain: definition and reporting standard...
https://doi.org/10.1161/STROKEAHA.108.515544
Stroke Al-Shahi Salman R, Berg MJ et. al.

Nov 1st, 2008 - Cavernous malformations of the brain (CMs) cause intracranial hemorrhage, but its reported frequency varies, partly attributable to study design. To improve the validity of future research, we aimed to develop a robust definition of CM hemorrhage....

see more →

Drugs  10 results see all →

Clinicaltrials.gov  64 results

Transcranial Direct Current Stimulation in Acute Ischemic Stroke Treatment
https://clinicaltrials.gov/ct2/show/NCT04801446

May 11th, 2022 - This prospective interventional single center randomized sham controlled dose-escalation study will assess safety, tolerability, feasibility and potential efficacy of transcranial direct current stimulation (tDCS) in acute stroke patients with sub...

Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector
https://clinicaltrials.gov/ct2/show/NCT05340127

Apr 22nd, 2022 - A prospective interventional study designed to assess the summative usability and rapidity of CEREBO® - a portable device to detect intracranial haemorrhage. 10 participants from a Primary Health Centre will be enrolled in this study. The particip...

Minimal Invasive Surgical Intracerebral Hemorrhage Removal
https://clinicaltrials.gov/ct2/show/NCT05138341

Apr 20th, 2022 - The proposed study seeks to determine whether hyperacute (≤8 hour) mechanical MIS management is feasible and improves outcome in patients with spontaneous supratentorial intracranial hemorrhage (ICH). Screening The subject will be evaluated as any...

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
https://clinicaltrials.gov/ct2/show/NCT05333666

Apr 19th, 2022 - Introduction: Non-vitamin K antagonist oral anticoagulants (NOAC) is the first line therapy to prevent ischemic stroke or systemic thromboembolism among atrial fibrillation (AF) patients. Since 2016, our study team enrolled patients under NOAC the...

Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
https://clinicaltrials.gov/ct2/show/NCT03574038

Apr 18th, 2022 - This is a single center, sham-controlled, dose escalation study where cathodal tDCS is delivered to threatened but not yet irreversibly damaged (penumbral) tissue in patients with large vessel occlusion who are not eligible for blood flow restorin...

see more →

News  478 results

Uncertain Results for Tenecteplase in 'Wake-up' Stroke
https://www.medscape.com/viewarticle/973876

May 12th, 2022 - In patients with "wake-up" stroke selected by noncontrast CT, treatment with tenecteplase did not significantly improve functional outcome at 90 days in the TWIST trial. Although tenecteplase treatment was associated with a higher proportion of pa...

Safety Concerns Halt High-dose Tenecteplase Stroke Study
https://www.medscape.com/viewarticle/973487

May 5th, 2022 - A study investigating a high dose (0.4 mg/kg) of the bolus thrombolytic tenecteplase in the treatment of patients with moderate to severe acute ischemic stroke was stopped prematurely because of increased rates of intracranial hemorrhage (ICH) and...

Dr. Wang on Adverse Effects of BTK Inhibitors in MCL
https://www.onclive.com/view/dr-wang-on-adverse-effects-of-btk-inhibitors-in-mcl

Mar 1st, 2022 - Michael Wang, MD, professor, Department of Lymphoma/Myeloma, founding and current director, Mantle Cell Lymphoma Program of Excellence, professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, the Unive...

FDA Approves First Drug for Myelofibrosis With Thrombocytopenia
https://www.medscape.com/viewarticle/969389

Mar 1st, 2022 - The US Food and Drug Administration (FDA) has granted accelerated approval for a new drug for the treatment of myelofibrosis, the first specifically for patients with low platelet counts. Pacritinib (Vonjo, CTI BioPharma) is indicated for use in t...

Are Thrombolytics for Stroke Safe for Patients on NOACs?
https://www.medscape.com/viewarticle/969163

Feb 25th, 2022 - Recent use of non-vitamin K antagonist oral anticoagulants (NOACs) is not associated with increased risk for bleeding following treatment with intravenous alteplase for ischemic stroke, new data suggest. In a prespecified, retrospective analysis o...

see more →

Patient Education  2 results see all →